Introduction
Raoultella Planticola is a gram-negative, non-motile, anaerobic bacterium of the Genus Raoultella most commonly found in water, soil, and aquatic environments 1 Originally classified as a member of the genus Klebsiella, it was reclassified as Raoultella spp. in 2001 based on 16S rRNA and rpoB gene sequencing. 1 This bacterium is a rare source of infection in humans; current literature provides few serious cases. The first Raoultella invasive human infection was found in 1984 in a patient with sepsis. 2 Most reported cases since then have been associated with bacteremia.
We present a case of R. Planticola in a patient with UTI, as well as a review of prior reported cases of R. Planticola associated with cystitis. There is weak evidence for susceptibility to R. Planticola cystitis; risk factors include immunosuppression, invasive procedures, and contaminated equipment [3] [4] [5] , Table 2 .
Case report
A 50-year old woman with lupus and a medical history of dysphagia, degenerative disc disease with lumbar-sacral spinal stenosis, and peripheral neuropathy underwent a total vaginal hysterectomy with bilateral salpingectomy, uterosacral ligament suspension, anterior and posterior repair, and cystoscopy for stage 4 utero-vaginal prolapses. Preoperatively she was on methotrexate. Her postoperative course was notable for failing her post-operative day one void trial and being discharged home with a foley catheter. She re-presented to our outpatient office on postoperative day 5 and subsequently passed the void trial. Two weeks later she presented with intermittent dull pain in her right lower quadrant, which had persisted for five days. The patient had also noticed small amounts of brown discharge. Her macroscopic urinalysis revealed she was positive for blood, nitrites, and +3 leukocyte esteraces. Urine culture was positive for Raoultella Planticola, sensitive to most antibiotics but resistant to Tetracycline. She was treated with Nitrofurantoin.
The patient returned for her routine post-operative appointment one month following surgery, shortly after being treated for UTI. She had completed the macrobid and her UTI symptoms had resolved. Her repeat culture showed no growth, confirming clearance of the bacteria.
Discussion
In recent years Raoultella spp. strains have been recognized as important emerging pathogens and should be seriously considered in cases of infection. Most recently, R. Planticola was discovered in a case of bacteremia-inducted fatal septic shock following a burn injury. Cystitis is the most common type of infection associated with R. Planticola. According to a 2015 retrospective review over a five-year period, 50% of R. Planticola infections were UTIs ( Table 2) . We identified 32 serious cases of human infection associated with Raoultella spp. reported between 1984 and 2018, of which 6 were associated with UTI (Table 1) . Other clinical infections resulting from R. Planticola growth have included septicaemia, pancreatitis and retroperitoneal abcess, pneumonia, cellulitis, cholangitis, necrotizing fasciitis, gastroenterocolitis, peritonitis, conjunctivitis, prostasis, appendicitis, surgical site infection, and catheter-related bacteremia ( Table 2 ).
The cause of R. Planticola infection cystitis is not well understood. According to a review of the literature, 4 out of 6 cases (Table 1) were attributed to immunosuppression. Immuno-compromised infection occurs when systemic impairment of the host immune system enables dormant colonizers to become invasive ( Table 2 ). The fifth case was reported in 2016 when a 57-year old man with end-stage renal disease and diabetes mellitus presented with dysuria, fever, chills, and suprapubic tenderness following urodynamic testing. The patient was diagnosed with cystitis by R. Planticola, and the infection was attributed to contaminated urodynamic testing equipment, in addition to immunosuppression. 4 The sixth case occurred in 2017 when a 56-year-old woman presented with recurrent urinary tract infections over a span of 4 months. Though the cause was unknown, it was hypothesized that seafood consumption and a history of urinary stress incontinence may have caused the infection ( Table 2 ). In our case, similar to other case reports, the patient developed an infection with R. Planticola due to immunosuppression from her lupus in the post-operative setting one week after catheter use. It is well documented that people with urinary catheters are at higher risk of developing a urinary tract infection. Table 2 References. 30 (4) from bacterial biofilm that forms in the catheter lumen. When organisms adhere to the film, they are essentially protected from host defenses (Table 2 ). Due to the immune-compromised state of our patient, catheterization both in and out of the hospital may have made her susceptible to this infection. Interestingly, this particular bacterium is usually found in aquatic environments, and she developed this in an urban setting. It is unclear where she may have been exposed to such a bacteria; however, we do practice in a metropolitan hospital where patients come from afar and possible cross-contamination could have occurred. Treatment for UTI with R. Planticola consists of a single course of antibiotics. In each case antibiotics have led to full recovery and resolution of symptoms. Antibiotics that have successfully treated R. Planticola UTI's include Ciprofloxacin, Ceftriaxone, Cefotaxime, Nitrofurantoin, Cephalexin, Cefpodoxime, and Ampicillin/Sulbactam. In our case report, we chose to treat with Nitrofurantoin, given its high sensitivity to most uropathogens ( Table 2 ). R. Planticola is an emerging pathogen in UTIs in immunosuppressed patients. It is imperative to consider this in the potential differential in such patients and understand treatment options including Nitrofurantoin as an affective agent to clear such infections.
